PI
ABUS icon

PFG Investments’s Arbutus Biopharma ABUS Stock Holding History

PFG Investments’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52.8K Hold
11,000
– – ﹤0.01% 1262
2026
Q1 		$49.5K Hold
11,000
– – ﹤0.01% 1155
2025
Q4 		$52.9K Sell
11,000
-2,500
-19% -$11.2K ﹤0.01% 1114
2025
Q3 		$61.3K Sell
13,500
-700
-5% -$2.57K ﹤0.01% 1076
2025
Q2 		$43.9K Hold
14,200
– – ﹤0.01% 1012
2025
Q1 		$49.6K Hold
14,200
– – ﹤0.01% 972
2024
Q4 		$46.4K Sell
14,200
-5,000
-26% -$18.4K ﹤0.01% 985
2024
Q3 		$73.9K Hold
19,200
– – ﹤0.01% 957
2024
Q2 		$59.3K Hold
19,200
– – ﹤0.01% 889
2024
Q1 		$49.5K Buy
+19,200
New +$49.7K ﹤0.01% 995

Other funds holding ABUS

TSC
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WCM
Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

PFG Investments's ABUS Position: Q2 2026 in Review

PFG Investments held its Arbutus Biopharma (ABUS) position steady in Q2 2026 at 11,000 shares worth $52.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1262.

PFG Investments first reported a position in ABUS in Q1 2024 and has held it in 10 quarters since. The position peaked at $73.9K in Q3 2024. 176 funds tracked by Wall St. Rank hold ABUS as of Q2 2026.

  • PFG Investments held 11,000 shares of Arbutus Biopharma worth $52.8K as of Q2 2026.
  • PFG Investments left its Arbutus Biopharma share count unchanged in Q2 2026.
  • Arbutus Biopharma made up ﹤0.01% of PFG Investments's portfolio in Q2 2026, its #1262 holding.
  • PFG Investments first reported a position in Arbutus Biopharma in Q1 2024 and has held it in 10 quarters since.
  • PFG Investments's Arbutus Biopharma position peaked at $73.9K in Q3 2024.
  • 176 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q2 2026.

Based on PFG Investments's 13F filing for Q2 2026, filed 23 Jul 2026.